SMALLPOX VACCINED CONTRACTS

Bavarian Nordic sees soaring revenue as pox vaccine orders mount

The company sees revenue for the year of around 6.00 billion Danish crowns ($862.99 million) against 3.15 billion crowns expected for 2022 with some 4.40 billion crowns coming from mpox and smallpox vaccined contracts alone.